As per a Reuters report, Dabur India’s subsidiaries were among the 57 companies sued in the U.S. and Canada. Customers allege that using their hair relaxer products causes ovarian cancer and other health issues. The news caused Dabur India’s shares to dip by as much as 2.5% in the morning extending its year-to-date decline over 6%. In an exchange filing on Wednesday, the company said, ‘currently, the cases are in the pleadings and early discovery phases of litigation…’Adding further, the allegations are based on an ‘unsubstantiated and incomplete’ study.
Recommended For You
Feedback
Select your Category
Your Message
No Network
Server Issue
Internet Not Available
Wait for it…
Log in to our website to save your bookmarks. It'll just take a moment.